Auxogyn gets rights to Stanford's reproductive technology
Auxogyn Inc. (women's reproductive products) has received exclusive rights to Stanford University's technology that will enable the company to develop diagnostics to improve the effectiveness of in vitro fertilization procedures.
- In Vitro Diagnostics
- Diagnostic Imaging Equipment & Supplies
- R&D and Marketing (Licensing)
Please contact Sales at: (212) 520-2765 or email PharmaNewsSales@informa.com